Skip to main content
NOVT
NASDAQ Manufacturing

Novanta Reports Q1 Revenue Growth, EPS Decline Amid Restructuring and New Geopolitical Risks

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$148
Mkt Cap
$4.995B
52W Low
$98.27
52W High
$149.95
52W Position info
51% above low
Off High info
1.3% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

NOVT sits 51% above its 52-week low of $98.27.

Summary

Novanta Inc. reported a 10.4% increase in Q1 revenue to $257.7 million, but diluted EPS decreased to $0.51 due to higher operating expenses and increased weighted average shares outstanding. The company is continuing its restructuring programs and highlighted new geopolitical risks.


Key Events · Earnings and Guidance · NOVT

  • Q1 Revenue Up 10.4%

    Novanta reported first-quarter revenue of $257.7 million, a 10.4% increase year-over-year, driven by growth in both Automation Enabling Technologies and Medical Solutions segments.

  • Diluted EPS Decreased

    Diluted earnings per share fell to $0.51 from $0.59 in the prior year, primarily due to increased weighted average common shares outstanding from a prior tangible equity unit offering and higher operating expenses.

  • Increased Restructuring Costs Impact Profitability

    Restructuring, acquisition, and related costs increased to $2.6 million in Q1 2026, compared to a gain in the prior year, contributing to a 15.1% decline in operating income. The company expects total 2025 restructuring charges to be approximately $25 million.

  • Active Share Repurchase Program

    Novanta repurchased $18.6 million in common shares during the quarter, completing its 2020 plan and continuing under the $200 million 2025 repurchase plan with $191.6 million remaining.


Analysis · NOVT · Manufacturing

Novanta's first-quarter results show solid revenue growth, but profitability was impacted by higher operating expenses and ongoing restructuring initiatives. The decline in diluted EPS, despite revenue gains, is a key concern for investors. The company's continued share repurchases indicate a commitment to returning capital, but the newly disclosed geopolitical risk factor adds a layer of uncertainty regarding future operational stability and costs.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NOVT was trading at $148.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5B. The 52-week trading range was $98.27 to $149.95. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NOVT - Latest Insights

NOVT
Nov 09, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $144.00
Real-time Price: $102.18 info
Change: -$41.82 (-29%) info
Market Cap: $3.857B info
NOVT
Nov 09, 2026, 4:50 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $102.18 info
Change: -$43.82 (-30%) info
Market Cap: $3.857B info
NOVT
Nov 09, 2026, 4:45 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $102.18 info
Change: -$43.82 (-30%) info
Market Cap: $3.857B info
NOVT
Oct 02, 2026, 4:30 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $149.27
Real-time Price: $102.18 info
Change: -$47.09 (-32%) info
Market Cap: $3.857B info
NOVT
Aug 05, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $158.00
Real-time Price: $102.18 info
Change: -$55.82 (-35%) info
Market Cap: $3.857B info